Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Woldemichael Website

Girma M. Woldemichael, Ph.D.

Selected Publications

1)  Giubellino A, Woldemichael GM, Sourbier C, Lizak MJ, Powers JF, Tischler AS, Pacak K.
Characterization of two mouse models of metastatic pheochromocytoma using bioluminescence imaging.
Cancer Lett. 316: 46-52, 2012.
2)  Woldemichael GM, Turbyville TJ, Vasselli JR, Linehan WM, McMahon JB.
Lack of a functional VHL gene product sensitizes renal cell carcinoma cells to the apoptotic effects of the protein synthesis inhibitor verrucarin A.
Neoplasia. 14: 771-7, 2012.
3)  Woldemichael GM, Turbyville TJ, Linehan WM, McMahon JB.
Carminomycin I is an apoptosis inducer that targets the Golgi complex in clear cell renal carcinoma cells.
Cancer Res. 71: 134-42, 2011.
4)  Grohar PJ, Woldemichael GM, Griffin LB, Mendoza A, Chen QR, Yeung C, Currier DG, Davis S, Khanna C, Khan J, McMahon JB, Helman LJ.
Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening.
J. Natl. Cancer Inst. 103: 962-78, 2011.
5)  Meragelman TL, Willis RH, Woldemichael GM, Heaton A, Murphy PT, Snader KM, Newman DJ, van Soest R, Boyd MR, Cardellina JH, McKee TC.
Candidaspongiolides, distinctive analogues of tedanolide from sponges of the genus Candidaspongia.
J. Nat. Prod. 70: 1133-8, 2007.
6)  Kim YH, Park EJ, Park MH, Badarch U, Woldemichael GM, Beutler JA.
Crinamine from Crinum asiaticum var. japonicum inhibits hypoxia inducible factor-1 activity but not activity of hypoxia inducible factor-2.
Biol. Pharm. Bull. 29: 2140-2, 2006.
7)  Woldemichael GM, Vasselli JR, Gardella RS, McKee TC, Linehan WM, McMahon JB.
Development of a cell-based reporter assay for screening of inhibitors of hypoxia-inducible factor 2-induced gene expression.
J Biomol Screen. 11: 678-87, 2006.
8)  Gutierrez-Lugo MT, Woldemichael GM, Singh MP, Suarez PA, Maiese WM, Montenegro G, Timmermann BN.
Isolation of three new naturally occurring compounds from the culture of Micromonospora sp. P1068.
Nat. Prod. Res. 19: 645-52, 2005.
9)  Woldemichael GM, Gutierrez-Lugo MT, Franzblau SG, Wang Y, Suarez E, Timmermann BN.
Mycobacterium tuberculosis growth inhibition by constituents of Sapium haematospermum.
J. Nat. Prod. 67: 598-603, 2004.
10)  Khera S, Woldemichael GM, Singh MP, Suarez E, Timmermann BN.
A novel antibacterial iridoid and triterpene from Caiophora coronata.
J. Nat. Prod. 66: 1628-31, 2003.
11)  Woldemichael GM, Wächter G, Singh MP, Maiese WM, Timmermann BN.
Antibacterial diterpenes from Calceolaria pinifolia.
J. Nat. Prod. 66: 242-6, 2003.
12)  Woldemichael GM, Singh MP, Maiese WM, Timmermann BN.
Constituents of antibacterial extract of Caesalpinia paraguariensis Burk.
Z. Naturforsch., C, J. Biosci. 58: 70-5, 2003.
13)  Woldemichael GM, Franzblau SG, Zhang F, Wang Y, Timmermann BN.
Inhibitory effect of sterols from Ruprechtia triflora and diterpenes from Calceolaria pinnifolia on the growth of Mycobacterium tuberculosis.
Planta Med. 69: 628-31, 2003.
14)  Woldemichael GM, Montenegro G, Timmermann BN.
Triterpenoidal lupin saponins from the Chilean legume Lupinus oreophilus Phil.
Phytochemistry. 63: 853-7, 2003.
15)  Woldemichael GM, Wink M.
Triterpene glycosides of Lupinus angustifolius.
Phytochemistry. 60: 323-7, 2002.
16)  Woldemichael GM, Wink M.
Identification and biological activities of triterpenoid saponins from Chenopodium quinoa.
J. Agric. Food Chem. 49: 2327-32, 2001.
Click Here to View Collapsed Bibliography.

This page was last updated on 5/28/2013.